Essential fatty acids and their metabolites could function as endogenous HMG-CoA reductase and ACE enzyme inhibitors, anti-arrhythmic, anti-hypertensive, anti-atherosclerotic, anti-inflammatory, cytoprotective, and cardioprotective molecules
<p>Abstract</p> <p>Lowering plasma low density lipoprotein-cholesterol (LDL-C), blood pressure, homocysteine, and preventing platelet aggregation using a combination of a statin, three blood pressure lowering drugs such as a thiazide, a β blocker, and an angiotensin converting enzy...
Main Author: | Das Undurti N |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2008-10-01
|
Series: | Lipids in Health and Disease |
Online Access: | http://www.lipidworld.com/content/7/1/37 |
Similar Items
-
Chronic Onset Form of Anti-HMG-CoA Reductase Myopathy
by: Noel Lorenzo Villalba, et al.
Published: (2021-06-01) -
Anti-HMG-CoA reductase, antioxidant, anti-urease potentials, and anti-leukemia properties of 4-Butylresorcinol as a potential treatment for hypercholesterolemia
by: Yanli Yu, et al.
Published: (2022-12-01) -
Anti-HMG-CoA reductase, antioxidant, and anti-inflammatory activities of amaranthus viridis leaf extract as a potential treatment for hypercholesterolemia
by: Shamala Salvamani, et al.
Published: (2016) -
Anti-HMG-CoA reductase, antioxidant, and anti-inflammatory activities of amaranthus viridis leaf extract as a potential treatment for hypercholesterolemia
by: Salvamani, Shamala, et al.
Published: (2016) -
Connexin hemichannels as candidate targets for cardioprotective and anti-arrhythmic treatments
by: Luc Leybaert, et al.
Published: (2023-03-01)